期刊文献+

高危型HPV DNA检测应用于体检中的价值探讨 被引量:20

Significance investigation of applying high risk-type HPV DNA detection in healthy examination
在线阅读 下载PDF
导出
摘要 目的:探讨高危型人乳头瘤病毒(HPV)DNA检测在筛查体检妇女宫颈癌前病变的临床应用价值。方法对2827例体检的已婚妇女做普通妇科检查后取样做超薄液基细胞学检查(TCT)和HPV 13种高危型DNA检测。结果高危型HPV的感染率为15.9%,3个不同年龄(<30岁、30~45岁、>45岁)体检组高危型HPV的感染率差异无统计学意义(P>0.05)。83.4%的HPV高危型感染者1年内感染可清除。372例高危型HPV DNA检测阴性者至少2年未有癌前病变或宫颈癌发生。宫颈光滑或轻度糜烂者与宫颈糜烂Ⅱ度及以上者间高危型HPV感染率差异有统计学意义(P<0.05)。TCT和高危型HPV DNA联合检测对宫颈癌前病变及宫颈癌的筛查率为72.7%。结论高危型HPV检测在妇女体检中的意义在于:高危型HPV感染的阴性预测和HPV的12个月以上的持续感染对宫颈癌的早期诊断、防治具有重要临床价值。TCT结合高危型HPV感染的检测更能有效地筛查宫颈癌及癌前病变。 Objective To investigate the clinical application significance of high risk-type human papillomavirus (HPV)DNA detection to screen cervix precancerous lesion in healthy examination.Methods A total of 2 827 married females for healthy examination did the common gynecological examination.Their samples were detected for thinprep cytology test (TCT)and HPV 1 3 high risk-type DNA.Results The infection rate of high risk-type HPV was 1 5 .9%, and the infection rates of high risk-type HPV in 3 different groups (<30 years old,30-45 years old and >45 years old) had no statistical significance (P>0.05 ).The 83.4% females who had high risk-type HPV infection could remove virus infection in 1 year,and 372 females who had no high risk-type HPV infection did not have precancerous lesion or cervical cancer at least 2 years.The infection rate of high risk-type HPV in 2 groups of cervix slick or low-degree erosion and cervical erosionⅡor above degree had statistical significance (P<0.05 ).The screen rate of cervix precancerous lesion and cervical cancer using TCT and high risk-type HPV DNA combination detection was 72.7%.Conclusions The application of high risk-type HPV DNA detection in healthy examination has early diagnosis,prevention and treatment significance in the negative prediction of high risk-type HPV infection and persistent infection of HPV above 1 2 months.TCT and high risk-type HPV DNA combination detection can screen cervical cancer and cervix precancerous lesion efficiently.
出处 《检验医学》 CAS 2014年第4期347-349,共3页 Laboratory Medicine
关键词 高危型人乳头瘤病毒 宫颈癌 体检 High risk-type human papillomavirus Cervical cancer Healthy examination
  • 相关文献

参考文献5

二级参考文献26

  • 1蔡虹.深圳市城区育龄妇女HPV感染状况调查[J].中国妇幼保健,2004,19(9):90-92. 被引量:46
  • 2李洁,刘宝印,zur Hausen H,王宏,杨学志,李力,刘文,刘洪隐,陆克昭,刘旭,牛春燕,裴润芳,苏钟浦,王言贵,董继华,张桂宁,刘春杰,许吉林,林毓纯.中国妇女宫颈癌组织中人乳头瘤病毒感染及其地理分布的调查[J].中华实验和临床病毒学杂志,1996,10(1):50-55. 被引量:68
  • 3黄志宏,钱德英,王丁,洪淡华,岑坚敏,舒焰红.人乳头状瘤病毒负荷量与宫颈癌及宫颈癌前病变的相关研究[J].中国妇幼保健,2006,21(11):1557-1559. 被引量:22
  • 4李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 5Franceschi S.The IARC commitment to cancer prevent ion:the example of papillom avirus and cervical cancer.Recent Results Cancer Res,2005,166(2):277-297.
  • 6Andersson S,Safari H,Mints M.Type distribution,viral load and intergration status of high 2 risk human papillomavirus in prestages of cervircal cancer.Br J Cancer,2005,92(12):2195-2200.
  • 7Houffiin DV,Collinct P,Vinafter D,et al.ValHe of human papillomavirus testing after conizafton by loop electrocurgicalexcision for high-grade squamous intraepi-thelial lesions.GynecolOncol,2008,90(3):587-592.
  • 8Ostor AG. Natural history of cervical intraepithelial neoplasia : a critical review [ J ]. Int J Gynecol Pathol, 1993, 12(2): 186-192.
  • 9Steenbergen RD, Kramer D, Braakhuis B J, et al. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia [ J ]. J Natl Cancer Inst, 2004, 96 (4) : 294-305.
  • 10Yoon SO. Abnormal fragile histidine triad (Fhit) ex- pression in invasive cervical adenocarcinoma : association with tumor aggressiveness [ J ]. Hum Pathol, 2007, 38(2): 326-331.

共引文献230

同被引文献169

  • 1徐慧芳,余艳琴,邵晨轶,张询,胡尚英,赵方辉,乔友林.DH3与cobas4800在宫颈癌筛查中的效果对比研究[J].中国肿瘤临床与康复,2020,0(2):129-132. 被引量:7
  • 2郑晓霞,李琼珍,李玲,胥琳璟.宫颈癌预后状况及其影响因素分析[J].实用癌症杂志,2014,29(3):314-316. 被引量:56
  • 3关婷,张志文,谢燕芳,黄玉新,刘琼霞.人乳头瘤病毒基因型与宫颈上皮内瘤样病变的关系[J].中国妇幼保健,2006,21(7):960-963. 被引量:35
  • 4Thierry F. Transcriptional regulation of the papillavirus oncogenesby cellular and viral transcription factros in cervical carcinoma[J].Virology,2009,384(2):375-379.
  • 5SKi JF,Belinson JL,Zhao FH,et al. Human, papillomavirus testingfor cervical cancer screening : results from a 6-year prospectivestudy in rural China[J]. Am J Epidemiol,2009,170(6) :708-716.
  • 6Franciscatto LG,Silva CM,Barcellos RB,et al.Comparison of urine and self-collected vaginal samples for detecting human papillomavirus DNA inpregnant women[J].Int J Gynaecol Obstet,2014,125(1):69-72.
  • 7Paaso AE,Louvanto K,Syrjnen KJ,et al.Lack of type-specific concordance between human papillomavirus(HPV)serology and HPV DNA detection in the uterine cervix and oral mucosa[J].J Gen Virol,2011,92(9):2034-2046.
  • 8Guan P, Howell -Jones R, Li N, et al. Human papillomavirus types in 115, 789HPV- positive women: a meta- analysis from cervical infection to cancer[ J]. Int J Cancer, 2012, 131 (10) : 2349 - 2359.
  • 9Vinodhini K, Shanmuqhapriya S, Das BC, et al. Prevalence and risk factors of HPV infection among women from various provinces of the world[ J]. Arch GynecolObstet, 2012, 285 (3): 771 - 777.
  • 10Canadian Task Force on Preventive Health Care, Dickinson J, Tsakonas E, et al. Recommendations on screening for cervical cancer[J]. CMAJ, 2013, 185(1): 35 -45.

引证文献20

二级引证文献106

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部